INGN

Inogen Inc

INGN
NasdaqSmall CapHealthcare

13F Pro Quality Score

31.9/100

Rank #2,444 of 2,962 stocks

View Healthcare peers →

Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Nov 14, 2026.

Revenue Growth

33.9/100

Profitability

25.2/100

Balance Sheet

18.8/100

Earnings Quality

45.8/100

Free Cash Flow

24.3/100

Institutional Flow

50.1/100

Revenue Scale

32.3/100

Dilution Risk

37.7/100

Price Chart

Email me the moment this company reports earnings
AI Research Report
Two-page plain-English analysis: business, thesis, and three scenarios for the next two years. Refreshed every quarter.
Upgrade to Pro
Pro: 5 reports/month · Pro+: unlimitedOpinion, not investment advice. Do your own research.
Reading the latest SEC filing… (first load can take ~20s)

Key Metrics

Revenue

Q2 2026
EDGAR

$95.08M

Net Income

Q2 2026
EDGAR

$-3.85M

EPS (Diluted)

Q2 2026
EDGAR

$-0.14

Operating Margin

Q2 2026
EDGAR

-5.4%

ROIC

Q2 2026
EDGAR

-11.7%

Free Cash Flow

Q2 2026
EDGAR

$2.23M

Top Institutional Holders

as of Q2 2026
$124.36M total

Financial Trends

Revenue & Net Income

Earnings Per Share

Loading ratio trend…